The four genetic variants—rs1802073 G>T in SFRP4, rs1105223T>C in CRB2, rs3821414T>C in ARHGEF3, rs11086065A>G in ANKLE1—could be validated as predictive markers for the response to acitretin in psoriasis. This evidence concerns the gene CRB2 and psoriasis.